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We hypothesized that the extent of frequency-dependent acceleration of relaxation (FDAR) would be less than that of isoprot-
erenol-(ISO-)dependent acceleration of relaxation (IDAR) at the same increment of heart rates, and ISO may improve FDAR.
Cardiac function and phosphorylation of PLB and cTnI were compared in pacing, ISO treatment, and combined pacing and
ISO treatment in isolated working heart. The increase in cardiac output and the degree of relaxation was less in pacing than
in ISO treatment at the same increment of heart rates. The increasing stimulation frequency induced more signiﬁcant relaxant
eﬀect in ISO perfusion than that in physiological salt perfusion. The pacing only phosphorylated PLB at Thr17, but ISO induced
phosphorylation of cTnI and PLB at Ser16 and Thr17. Those results suggest that the synergistic eﬀects of PLB and cTnI induce
higher degree of relaxation which makes a suﬃcient diastolic ﬁlling of the ventricle at higher heart rate.
1.Introduction
Heart rate is a fundamental physiological modulator of car-
diacfunctioninallmammalianhearts.Regardlessofwhether
the force-frequency relationship is positive or negative, an
increaseinheartrateisalwaysassociatedwithanacceleration
of relaxation, named as frequency-dependent acceleration of
relaxation (FDAR) [1]. This FDAR ensures the proper relax-
ationanddiastolicﬁllingoftheventricleathigherheartrates.
Previous studies indicate that Ca2+/Calmodulin-dependent
kinase II (CaMKII) is a prime candidate in sensing and
mediating frequency-dependent eﬀects [2]. The CaMKII has
at least four substrates involved in excitation-contraction
coupling in the heart [3]. Published studies demonstrate
that CaMKII can phosphorylate ryanodine receptor (RyR)
[4], sarcoplasmic reticulum Ca2+-ATPase (SERCA) [5],
phospholamban (PLB) [6], and the L-type Ca2+ channels
(LTCC)[7].ThephosphorylationofLTCCandRyRisrelated
to modulation to systolic function. It has been reported that
LTCC activation by CaMKII is involved in the development
of early afterdepolarizations and arrhythmias in vitro and
in vivo [8]. Huke and Bers found that FDAR did not rely
on phosphorylation of RyR [1]. Valverde et al. reported that
SERCA phosphorylation by CaMKII was not involved in
FDAR [9]. Thus, a very likely target of FDAR is PLB, an
inhibitor of SERCA [10]. When PLB becomes phosphory-
lated at Thr-17 by CaMKII, the inhibition is relieved, and
Ca2+ uptake of SR is accelerated [10]. However, increasing
stimulation frequency still induces FDAR in PLB knock-
out mouse hearts [11]. Therefore, the molecular mecha-
nism of FDAR is still controversial.
Activationofthesympatheticnervoussystemleadstothe
secretion of catecholamines, which stimulate β-adrenergic
receptors in the heart. Isoproterenol-(ISO-)dependent accel-
eration of relaxation (IDAR) is another important intrinsic
regulator to cardiac function. Stimulation of β-adrenergic
receptor (β-AR) by ISO activates Gs, which in turn activates
adenylate cyclase and increases the formation of cAMP
within cardiomyocytes. Elevated levels of cAMP increases
the activation of protein kinase A (PKA) which phos-
phorylates intracellular targets such as LTCC, RyR, PLB,
cardiac troponin I (cTnI), and myosin binding protein C
(MyBPC). Phosphorylation of LTCCs enhances Ca2+ inﬂux
whichincreasesshorteningamplitudeorforceofcontraction2 Journal of Biomedicine and Biotechnology
[7]. Recently, MacDonnell et al. reported that adrenergic
regulation of cardiac contractility did not involve phospho-
rylation of the cardiac RyR at serine-2808 residue [12].
Phosphorylation of MyBPC does not appear to have any
eﬀect on myoﬁbrillar Ca2+ sensitivity which modulates
relaxation but accelerated the kinetics of force develop-
ment [13]. Phosphorylated MyBPC may link to myocardial
protection in ischemia [14, 15]. The elevated intracellu-
lar Ca2+ concentration increases the activity of SERCA
which indirectly accelerates relaxation of cardiomyocytes.
The phosphorylated PLB at Ser-16 and Thr-17 by PKA
also enhanced the activity of SERCA. The phosphorylation
of cTnI reduced the Ca2+ sensitivity of myoﬁbrils which
facilitates Ca2+ dissociation from myoﬁbrils [16]. Therefore,
phosphorylation of PLB and cTnI may be two synergistic
modulators to accelerate relaxation in ISO stimulation.
The increasing frequency of stimulation only phospho-
rylates one site of PLB, but not cTnI. Due to lack of the
synergistic eﬀect between PLB and cTnI, we hypothesized
that the extent of FDAR would be less than that of IDAR at
the same increment of heart rate, the less extent of FDAR
may have a limitation on the suﬃcient diastolic ﬁlling of the
ventricle with increasing frequency of stimulation, and ISO
may improve FDAR. Therefore, the aim of the present study
was to compare the cardiac function and extent of relaxation
between FDAR and IDAR at the same increment of heart
rate and further to observe the extent of FDAR during ISO
stimulation.
2.MaterialsandMethods
2.1. Preparation of Isolated Working Heart. Sprague-Dawley
rats weighing 220 ± 10g were used. The animal procedure
described here has been approved by the Animal Care and
Use Committee at the Fourth Military Medical University.
The isolated crystalloid-perfused rat heart has previously
been described [17]. Rats were heparinized (500Ui.p.) and
anesthetized (sodium pentobarbital, 40mg/kgi.p.). Hearts
were excised, immediately mounted, and perfused on a Lan-
gendorﬀ apparatus (Radnoti, USA) at a constant pressure of
60 mmHg with Krebs-Henseleit solution (in mM: 118 NaCl,
4.7KCl,2.25MgSO4,2.25CaCl2,23.8NaCO3,1.2N aH 2PO4,
0.32 EDTA, and 11.5 D-glucose) in a nonrecirculating retro-
grade mode. The time from excision to perfusion was less
than 60 seconds. The perfusate was oxygenated with a gas
mixture of 95% O2-5% CO2, achieving pH of 7.39 to 7.41.
Leftatriumwascannulatedthroughthepulmonaryveinwith
steel cannula (inside diameter: 1.8mm; outside diameter:
2.0mm). In order to detect the intraventricular pressure,
an ultraminiature pressure catheter transducer (model SPR-
671; Millar Instruments, Houston, USA) was put into the
left ventricle through the left atrium. The preload was set
up at 10mmHg. The heart was then switched from the
Langendorﬀ to a working mode. The aortic and coronary
ﬂow was recorded at the 1st, 5th, 10th, and 15thmin at
the working heart mode. Electrodes placed on the aortic
cannula and the apex of the ventricle were connected to a
square wave stimulator (Aurora Scientiﬁc Inc., Canada, 5ms
pulse duration, 20V pulse amplitude). Hearts were paced at
300, 360, and 420beats/min in the absence and the presence
of isoproterenol (ISO, Sigma Chemical Co.). The hearts
were superfused with 1.0, 10.0, and 20.0nM of ISO for at
least 5min. The aortic ﬂow, coronary ﬂow, heart rate, left
ventricular end-systolic (LVESP) and end-diastolic (LVEDP)
pressure, and maximal rates of left ventricular pressure
development (+dP/dtmax) and relaxation (−dP/dtmax)w e r e
measured to evaluate the contractile function of isolated
working heart. Cardiac output is equal to aortic ﬂow plus
coronary ﬂow. Data was acquired and analyzed using a
PowerLab system and Chart software (ADInstruments Inc.,
Sydney, Australia).
2.2. Intracellular Ca2+ Measurement of the Single Cardiomy-
ocyte. The ventricular myocyte isolation was the same as
that described previously [18]. The cannulated hearts were
mountedonaLangendorﬀperfusionapparatusandperfused
withCa2+-free Joklik’s modiﬁed minimum essential medium
(Sigma-Aldrich, St. Louis, Mo, USA) containing 10mM
HEPES, 0.1% bovine serum albumin (BSA). After 5min,
the perfusate was switched to a circulating enzyme solution
containing 0.08% collagenase I (Sigma-Aldrich) for 30min.
All the perfusion procedure was performed at 37◦Ci n
a constant ﬂow, and the perfusion pressure was monitored.
Then the ventricular tissues were chopped, and the car-
diomyocytes were dispersed gently by a wide tipped pipette.
Thecellsuspensionwasﬁlteredthrough200-μmnylonmesh.
After 30min, the cells were resuspended in Joklik’s medium
containing 1% BSA and slowly recovered Ca2+ concentration
to 1.25mM.
The intracellular Ca2+ concentration of cardiomyocytes
was measured within 6 hours after isolation. Ventricular
myocytes were loaded with fura-2 AM (5μM) for 30min in
the dark at room temperature. Cells were then transferred
into a 0.2mL chamber which was on the stage of an inverted
microscope (OlympusX71, Tokyo, Japan). Cells were super-
fused with Tyrode solution (in mM: 132 NaCl, 4.8 KCl, 1.2
MgCl2,1 . 8C a C l 2,5 . 0s o d i u mp y r u v a t e ,1 0H E P E S ,a n d1 0
D-glucose, pH 7.40) at a ﬂow rate of 0.2mL/min at 37◦C.
Electric ﬁeld stimulus (rectangle wave, 15V, 5ms, 1.0Hz)
was given by the stimulator. Then the stimulation frequency
increased to 2Hz, 5Hz, and 10Hz with or without ISO
perfusion (1, 10, and 20nM).
Intracellular Ca2+ concentration was measured by whole
cell photometry (DeltaRam, Photon Technology Interna-
tional, USA). The emission ratio at 510nm, during alternate
excitation at 340nm and 380nm was used to determine
intracellular Ca2+ concentration. Fluorescence emission was
measured at 240points/s for each of the excitation wave-
lengths. Background ﬂuorescence values were determined at
each excitation wavelength. These background values were
subtracted from the recordings made at each wavelength
during each experiment. Data were acquired and analyzed
by Felix software (Version 1.4, Photon Technology Inter-
national). Ca2+ transient amplitudes were the diﬀerence
between systolic and diastolic Ca2+.
2.3. Western Blotting. The expressions of cTnI, total and Ser-
16-phosphorylated and Thr-17-phosphorylated PLB wereJournal of Biomedicine and Biotechnology 3
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Figure 1:CardiacoutputofisolatedworkingheartsinthepacingandISOtreatment.Alldataaremean ±SEM.(a)Cardiacoutputofisolated
working hearts in diﬀerent rates of pacing. The n = 6 hearts. ∗P<0.05 versus baseline. (b) Cardiac output in diﬀerent concentrations of
ISO treatment. The n = 6 hearts in each ISO concentration. ∗P<0.05 or ∗∗P<0.01 versus baseline. (c) The percentage increases in cardiac
output in the heart rate increment of 60beats/min. The n = 6 hearts for each group. ∗P<0.05 versus the pacing group. (d) The percentage
increases in cardiac output at the pacing of 420beats/min without and with ISO treatment. The n = 6 hearts in each ISO concentration.
∗P<0.05 or ∗∗P<0.01 versus baseline.
detected by Western blotting. Left ventricular myocardium
was homogenized in a buﬀer containing 50mM potassium
phosphate buﬀer (pH 7.0), 0.5mM DTT, 1mM EDTA,
0.3mM PMSF, and phosphatase inhibitor cocktail (1:100,
Sigma-Aldrich). Samples were subjected to SDS-PAGE in
polyacrylamide gels (12% or 14% depending on protein
molecular weight). After electrophoresis, protein was elec-
trically transferred to nitrocellulose membrane (0.45μm
pore size) using a Bio-Rad semidry transfer apparatus.
The blotted nitrocellulose membranes were blocked with
1% bovine serum albumin in Tris-buﬀered saline (150mM
NaCl, 50mM Tris–HCl, and pH 7.5) and incubated with
mouse monoclonal anti-TnI (TnI-1, 1:4,000; Courtesy of
Dr. J.-P. Jin), mouse monoclonal anti-PLB (1:1000; Cell
Signaling Technology, Inc. (CST), Danvers, Mass, USA), rab-
bit polyclonal anti-Ser-16-phosphorylated phospholamban
(Phospho16-PLB, 1:1000; CST) and rabbit polyclonal anti-
Thr-17-phosphorylated phospholamban (Phospho17-PLB,
1:1000; Santa Cruz Biotechnology, Inc., Santa Cruz, Calif,
USA) in TBS containing 0.1% BSA at 4◦C overnight. The
membranes were visualized with IRDye 680CW goat anti-
mouse or IRDye 800CW goat antirabbit secondary antibod-
ies (1:10,000, for 90min at room temperature) using an
Odyssey scanner (LI-COR Biosciences, Lincoln, Neb, USA).
Quantiﬁcation analysis of blots was performed with the
Scion Image software.
2.4. Statistical Analysis. Data are expressed as mean ± SEM.
Diﬀerences between groups were evaluated using one-way
analysis of variance (ANOVA). When ANOVA indicated sig-
niﬁcance, a Dunnett post-hoc test was performed. P<0.05
was considered statistically signiﬁcant.4 Journal of Biomedicine and Biotechnology
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Figure 2: Left ventricular end-systolic pressure (LVESP) and end-diastolic pressure (LVEDP) of working hearts in the pacing and ISO
treatment. (a) and (c) LVESP and LVEDP during the pacing. (b) and (d) LVESP and LVEDP in ISO treatment. Data are mean ± SEM, n = 6
hearts for each ISO concentration in each group. ∗P<0.05 versus baseline.
3. Results
3.1. Systolic and Diastolic Function of Isolated Working Hearts
during the Pacing and ISO Treatment. At the preload of
10mmHg and afterload of 60mmHg, the intrinsic heart rate
of working heart was 236.4 ± 6.4beats/min in the baseline
group. Heart rates increased to 259.9 ± 7.3, 288.1 ± 4.1,
and 316.7 ± 6.3beat/min in 1, 10, and 20nM ISO stimu-
lation, respectively. At baseline, cardiac output was 27.3 ±
0.5mL/min. Cardiac output decreased to 24.7 ± 0.9mL/min
at the pacing of 300beats/min, then increased to 27.5 ±
0.7mL/min and 29.3 ± 0.9mL/min at the pacing of 360
and 420beats/min (Figure 1(a)). Cardiac output increased
to 28.7 ± 0.9, 32.2 ± 0.4, and 33.5 ± 0.3mL/min in 1,
10, and 20nM ISO treatment, respectively, (Figure 1(b)).
Whiletheincrementofheartratewassimilarat60beats/min,
the percentage increase in cardiac output was higher in
ISO-treated group than in the pacing group (Figure 1(c)).
Cardiacoutputhadabout7%,10%,15%,and24%increases,
respectively, at the pacing of 420beats/min without and with
1, 10, and 20nM ISO treatment compared to the baseline at
the intrinsic heart rate (Figure 1(d)).
LVESP decreased with the increasing pacing rate
(Figure 2(a)). In the opposite, LVESP increased with the
increasing concentrations of ISO at the intrinsic heart
rate (Figure 2(b)). LVEDP showed a signiﬁcant increase
at 300beats/min but decreased progressively at 360 and
420beats/min (Figure 2(c)). LVEDP decreased progressively
with the increasing concentrations of ISO at the intrinsic
heart rate (Figure 2(d)).
The ±dP/dtmax decreased signiﬁcantly at the pacing of
300beats/min and increased at the pacing of 360 and
420beats/min (Figure 3(a)). In contrast, ±dP/dtmax elevated
progressively with the increasing concentrations of ISO
(Figure 3(b)). TR75, time from peak to 75% relaxation of
left ventricular pressure, is another index of cardiac diastolic
function. Both the pacing and ISO stimulation reduced TR75
(Figures 3(c) and 3(d)).Journal of Biomedicine and Biotechnology 5
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Figure 3: Maximal rates of left ventricular pressure development and relaxation (±dP/dtmax) and time from peak to 75% relaxation (TR75)
of left ventricular pressure. (a) and (c) ±dP/dtmax and TR75 under diﬀerent rates of pacing. (b) and (d) ±dP/dtmax and TR75 in diﬀerent
concentrations of ISO treatment. Data are mean ± SEM, n = 6 hearts for each ISO concentration in each group. ∗P<0.05 or ∗∗P<
0.01 versus baseline.
The percentage increases in ±dP/dtmax between the pac-
ing of 420 beats/min and intrinsic heart rate groups with-
out ISO stimulation were 7.1 ± 1.0% and 9.7 ± 1.1%,
respectively, (the baseline values in Figure 4(a)). Under ISO
stimulation, the pacing of 420beats/min induced an addi-
tional enhancement. The percentage increases in ±dP/dtmax
between the pacing of 420beats/min and intrinsic heart rate
groups increased progressively with the increasing concen-
trations of ISO (Figure 4(a)). The pacing of 420beats/min
led about 13% shortening in TR75 without ISO stimulation.
Under ISO treatment, the pacing of 420beats/min showed
stronger relaxant eﬀects than that of the baseline group
(Figure 4(b)).
3.2. Intracellular Ca2+ Concentrations of the Cardiomyocyte in
the Pacing and ISO Treatment. The resting intracellular cal-
cium concentration ([Ca2+]i) increased with the increasing
frequency of stimulation; higher frequency of stimulation
(i.e., >5Hz) induced a signiﬁcant elevation in resting [Ca2+]i
of cardiomyocytes (Figure 5(a)). The peak [Ca2+]i increased
toamaximallevelat5Hz,thendecreasedslightlyat10Hz.In
contrast, the resting [Ca2+]i decreased slightly, but the peak
[Ca2+]i kept elevating with the increasing concentrations
of ISO (Figure 5(b)). Under ISO perfusion, the increasing
degrees of resting [Ca2+]i were less compared with non ISO-
treated group while the frequency of stimulation increased
from 300 to 420beats/min (Figure 5(a)). The peak [Ca2+]i
still elevated with the increasing frequency of stimulation
during diﬀerent concentrations of ISO treatment. The peak
[Ca2+]i reached the maximal level at 10Hz under 20nM ISO
treatment (Figure 5(a)).
TD75, the time from peak to 75% decay in calcium tran-
sient, reduced both under increasing frequency of stimula-
tion and ISO perfusion. The degrees of reduction in TD75
were lower in stimulation group than in ISO-treated group
(Figures 5(c) and 5(d)).
3.3. The Phosphorylation of cTnI at Ser23/24 and PLB at Ser16
and Thr17 in the Pacing and ISO Treatment. Figure 6(a)6 Journal of Biomedicine and Biotechnology
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Figure 4: Percentage increases in ±dP/dtmax and TR75 under combined eﬀect of the pacing and ISO. (a) The percentage increases in
±dP/dtmax between the pacing of 420beats/min and intrinsic heart rate without and with ISO treatment. (b) The percentage shortenings
in TR75 between the pacing of 420beats/min and intrinsic heart rate without and with ISO treatment. Data are mean ± SEM, n = 6 hearts
for each ISO concentration in each group. ∗P<0.05 or ∗∗P<0.01 versus baseline.
shows the representative Western blots of cTnI and phos-
phorylated cTnI at Ser23/24. There were no diﬀerences in
expression of cTnI in the pacing, ISO treatment, and pacing
plusISOtreatmentgroups(Figure 6(b)).Phosphorylationof
cTnI at Ser23/24 showed a dose-dependent increase in ISO
perfusion. But the pacing had no eﬀect on phosphorylation
of cTnI at Ser23/24 in basic and ISO-treated condition
(Figure 6(c)).
Figure 7(a) shows the representative Western blots of
PLB, phosphorylated PLB at Ser16, and Thr17 in isolated
working hearts under the pacing and diﬀerent concentra-
tions of ISO perfusion. Total PLB, which is the sum of
pentameric and monomeric PLB, did not change under
the pacing and ISO perfusion (Figure 7(b)). The phospho-
rylation of PLB at Ser16 and Thr17 also showed a dose-
dependent increase in ISO stimulation. The degrees of
phosphorylated PLB at Ser16 elevated from 39.3 ± 1.4%
in baseline to 50.2 ± 1.7% in 20nM ISO treatment, and
the degrees of phosphorylated PLB at Thr17 increased from
13.9 ± 0.6% in baseline to 22.5 ± 0.6% in 20nM ISO
treatments (Figures 7(c) and 7(d)). The phosphorylation of
PLB at Thr17 increased with the increasing pacing rate, but
the pacing did not alter the phosphorylation of PLB at Ser16.
During 10nM and 20nM ISO perfusion, the pacing induced
anadditionalincreaseinthephosphorylationofPLBatSer16
in a frequency-dependent manner (Figure 7(d)).
4. Discussion
4.1. Coordinated Activation of Ca2+ Handing Proteins in
Excitation-Contraction Coupling Is Important to Considerably
Accelerate Relaxation in ISO Stimulation. In the present
study, the increase in maximal rate of relaxation and the
shortening in TR75 were lower in the pacing than in ISO
stimulation (Figure 4(a)). It indicates that the extent of
FDAR is less than that of IDAR. FDAR is an important
intrinsicregulatortocardiacfunctioninphysiologicalcondi-
tion. However, the mechanism of FDAR is still controversial.
Some studies reported that FDAR may be related to the
activation of CaMKII, phosphorylation of PLB, and the
increase of SERCA activity. There are evidences to indicate
that inhibition of CaMKII by KN-93 [9], CaMKII and PLB
knock-out [11, 19], or inhibition of SERCA also shows an
acceleration of relaxation in the increasing stimulation
frequency [11]. We observed that the pacing only increased
the phosphorylation of PLB at Thr-17 site (Figure 7). The
increase in Thr-17 phosphorylation of PLB was associated
with FDAR, but the relaxation eﬀect was weak. The Thr-17
phosphorylation of PLB can relieve the inhibition to SERCA.
Since the activation of SERCA by Thr-17 phosphorylation
of PLB is low, the resting intracellular Ca2+ concentration
slightly elevated with an increasing stimulation frequency
(Figure 5(a)).Incontrast,ISOtreatmentshowednotonlythe
phosphorylation of PLB at Ser-16 and Thr-17 sites, but also
the cTnI phosphorylation (Figure 7(a)). Several researches
have indicated that PLB phosphorylation by ISO stimulation
is a dominant mediator to the acceleration of relaxation in
PLB knock-out mouse [20]. But it should not be ignored
that the eﬀect of cTnI phosphorylation was induced by ISO
treatment on the acceleration of relaxation.
Early investigations indicate that phosphorylation of
cTnImaynotbeimportantintherelaxanteﬀectofISOstim-
ulation. Johns et al. found no eﬀect of cTnI phosphorylation
by PKA on the relaxation in skinned guinea pig ventricular
trabeculae [21], and the precise experimental conditions
may be important in this regard. Recently, many studiesJournal of Biomedicine and Biotechnology 7
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Figure 5: Resting and peak calcium concentrations in cardiomyocytes and time from peak to 75% decay (TD75) under diﬀerent frequencies
of stimulations with and without ISO treatment. Data are mean ± SEM, n = at least 30 myocytes from six hearts for each concentration in
each group. At least 5 myocytes were from each heart. ∗P<0.05 or ∗∗P<0.01 versus baseline.
indicate that phosphorylation of cTnI by PKA may be partic-
ularly important in modulating diastolic function of hearts.
Fentzke et al. constructed transgenic mice (TG-ssTnI); the
myocardium expressed slow skeletal TnI (ssTnI) which lacks
N-terminal extension containing two PKA phosphorylation
sites. They reported that in situ relaxation of left ventricular
pressure was signiﬁcantly slowed in TG-ssTnI hearts com-
paredwiththewild-typemice[22].Kentishetal.alsostudied
transgenic mice with ssTnI replacing cTnI and used ﬂash
photolysis of diazo-2 to rapidly remove Ca2+ from skinned
cardiac muscle ﬁbers. Myocardium expressing ssTnI had
no acceleration of relaxation in β-adrenergic stimulation,
suggesting that cTnI phosphorylation played an important
role in intrinsic relaxation [23]. Li et al. reported the ﬁrst
quantitative estimates of the relative contributions of PLB
and TnI phosphorylation to the ISO induced acceleration of
relaxation in mouse hearts. The TnI phosphorylation may
contribute up to 14–18% of the acceleration of relaxation
in response to ISO during isometric contractions in mouse
myocardium [20]. Wolska et al. observed four lines of
mice expressed PLB/cTnI, PLB/ssTnI, PLBKO (PLB knock-
out)/cTnI, and PLBKO/ssTnI in the heart, respectively. They
demonstrated that expression of ssTnI in hearts of PLB
knock-out mice altered the relaxant eﬀect of β-adrenergic
stimulation [24]. The underlying mechanisms of phospho-
rylation of cTnI by PKA regulating relaxation of hearts may
be involved in myoﬁbril Ca2+ sensitivity [16], an increase
in crossbridge cycling [23], and increased binding of cTnI8 Journal of Biomedicine and Biotechnology
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Figure 6: Expressions of cTnI and phosphorylated cTnI at Ser23/24 in the myocardium after the pacing and ISO treatment. (a) The
representative Western blots of cTnI and phosphorylated cTnI at Ser23/24. (b) Expression of total cTnI which is the sum of cTnI and
NH2-terminal deleted fragment of cTnI (cTnI-ND). (c) The phosphorylation of cTnI. Data are mean ± SEM, n = 6 hearts in each group.
∗P<0.05 or ∗∗P<0.01 versus baseline.
to the thin ﬁlament. The phosphorylation of cTnI reduces
Ca2+ sensitivity of myoﬁbrils which accelerates the rate of
Ca2+ dissociation from cardiac troponin C. Taken together,
phosphorylation of PLB and cTnI induces a synergistic eﬀect
to accelerate relaxation in ISO administration. Therefore,
IDAR is stronger than FDAR. The less extent of FDAR
elevates LVEDP which induces an insuﬃcient diastolic ﬁlling
at higher heart rate and further may reduce cardiac output.
4.2. The Phosphorylation of cTnI Causes a Synergistic Eﬀect
between PLB and cTnI and Further Enhances the Relaxation
in Increasing Frequency of Stimulation. Although PKA phos-
phorylates many sites in the cardiomyocyte, only phospho-
rylated PLB and cTnI are directly related to the acceleration
of relaxation in ISO stimulation. Due to the synergistic eﬀect
of PLB and cTnI, the degree of relaxation in IDAR is higher
than that in FDAR. In this study, the degrees of relaxation
in increasing rate of pacing showed the additional increases
during ISO perfusion. Varian and Janssen reported that
FDAR involved decreased myoﬁlament calcium sensitivity
[25]. Phosphorylation of cTnI can reduce myoﬁlament cal-
cium sensitivity. It suggests that phosphorylation of cTnI
would be helpful to FDAR. Takimoto et al. generated trans-
genic mice that overexpress cTnI in which the serine residues
normally targeted by PKA were mutated to aspartic acid
to mimic constitutive phosphorylation (cTnI-P22P23). The
cTnI-P22P23 hearts showed a frequency-dependent enhance-
ment of systolic and diastolic in vivo and afterload sensitivity
of relaxation [26]. Using similar transgenic mice, Sakthivel
et al. also demonstrated that the cTnI-P22P23 hearts showed
augmented relaxation and contraction at higher heart rates
compared with the nontransgenic controls [16].
The 10nM of ISO induced about 50% phosphorylation
of cTnI, 45% phosphorylation of PLB at Ser-16 site, and
14% phosphorylation of PLB at Thr-17 site in the present
study. These results are in agreement with the experi-
ments of Kuschel and colleagues [27]. The phosphorylation
of cTnI by ISO stimulation showed an enhancement in
the extent of FDAR compared with that in the absence
of ISO. While 90% of the cTnI was phosphorylated inJournal of Biomedicine and Biotechnology 9
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Figure 7: Expression of PLB, phosphorylated PLB at Ser16 (phospho Ser16-PLB) and at Thr17 (phospho Thr17-PLB) in the myocardium
after the pacing and ISO treatment. (a) The representative Western blots of PLB, phosphorylated PLB at Ser16 and Thr17. (b) Expression of
total PLB measured by pentametric plus monomeric forms. (c) Expression of phospho Ser16-PLB. (d), expression of phospho Thr17-PLB.
Data are mean ± SEM, n = 6 hearts in each group. ∗P<0.05 or ∗∗P<0.01 versus baseline.
20nM of ISO treatment, the PLB Ser-16 and Thr-17 had
50% and 22% phosphorylation, respectively. The extent of
FDAR in the presence of 20nM ISO further increased. The
additional enhancement in phosphorylation of PLB Thr-
17 may form a synergistic eﬀect with phosphorylation of
cTnI by PKA with increasing stimulation frequency, and
hence, the extent of FDAR increased. Finally, cardiac output
increased in the presence of ISO rather than decreased in the
absence of ISO.
In summary, this study provides evidence supporting
an important role for cardiac TnI phosphorylation by
PKA in the enhancement of diastolic function. And the
synergistic eﬀects between the PLB and cTnI are neces-
sary in promoting relaxation, especially at higher heart
rate.
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